Previous Article | Next Article 
Appl Environ Microbiol, July 1998, p. 2721-2722, Vol. 64, No. 7
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Use of Luciferase Genes as Biosensors To Study
Bacterial Physiology in the Digestive Tract
G.
Corthier,1,*
C.
Delorme,2
S. D.
Ehrlich,2 and
P.
Renault2
Unite d'Ecologie et de Physiologie
Digestive-FBI1 and
Génétique
Microbienne,2 Institut National de la
Recherche Agronomique, 78352 Jouy-en-Josas Cedex, France
Received 25 November 1997/Accepted 15 April 1998
 |
ABSTRACT |
A method based on the use of the bacterial luciferase genes was
developed in order to investigate Lactococcus lactis gene expression in the mouse digestive tract. Germfree mice were
monoassociated with different strains containing transcriptional
fusions of promoters with the luciferase genes. Our results demonstrate
that this method is readily applicable to the study of promoter
strength and physiology of bacteria in the digestive tract.
 |
TEXT |
Lactic acid bacteria are widely used
in food technology and may have a so-called "probiotic effect"
(4, 10). However, the metabolic activities of these bacteria
in the digestive tract (DT) remain uncertain, and this fact impairs our
understanding of the beneficial effect of these organisms on health.
The lactic acid bacteria adapt their metabolism to the environment by
synthesizing proteins whose activities are required for survival and,
eventually, proliferation. The level of transcription of regulated
promoters reflects the need of the cells for particular functions
according to the physiological state and environment stimulation. The
activity of regulated promoters, therefore, reflects the physiological state of the cells.
Moreover, the use of lactic acid bacteria as vectors for new molecules
with targeted activity in hosts is being investigated (5, 11,
18). Being able to measure promoter strength in the DT is a
prerequisite for expression of heterologous proteins at suitable
levels. This paper presents an experimental model for studying promoter
activities in the DT by using the bacterial luciferase gene as a
reporter gene.
Lactococcus lactis was grown in M17 (17) or
chemically defined medium (CDM) (13) supplemented with
erythromycin (5 µg/ml). Thermoresistant Bacillus subtilis
spores were used as transit markers (2). The L. lactis strains used are derivatives of NCFB2118 (National
Collection of Industrial and Marine Bacteria, Aberdeen, United Kingdom)
containing integrative plasmids or transposons. These elements carry
the lux genes from Vibrio harveyi fused with L. lactis promoters as described previously (15).
A fragment from pJIM2366 (15) containing the fusion of
lux genes and Pald, the promoter for
the acetolactate decarboxylase gene from L. lactis (fragment
from position 24152 to 24716 from GenBank sequence accession no.
V92974), with an erythromycin marker was subcloned in the HindIII site present in tetM from
Tn916 carried by pBluescript (Stratagene, CF). This
construction was used to replace the tetM gene from
Tn916 by transformation of a derivative of B. subtilis 168 (1). JIM5192 was obtained by introducing
the transposon into NCFB2118 by conjugation. JIM5206, JIM5213, and
JIM5460 are transformants of NCFB2118 containing the luxAB
gene fused with the his promoter
(Phis; segment fragment from position 1 to 1296 from GenBank sequence accession no. M90760), a truncated derivative of
the his promoter (PhisD3; segment
fragment from position 1 to 948), and the mleS promoter
(Pmle; segment fragment from position 1 to 468 from GenBank sequence accession no. X75982), respectively. The plasmids
used to integrate these fusions into the chromosome are derivatives of
pORI28 (9), and the method used to select single crossover
events has been described previously (6).
Germfree C3He/J mice (10 mice per group) were reared in a Trexler
isolator fitted with a rapid transfer system (La Calhène, Vélizy, France). All materials introduced into the isolator were sterilized by irradiation or heating. Each mouse received 0.5 ml of a
24-h culture of L. lactis (about 4 × 108
CFU/ml) by the orogastric route. Malate inoculation was performed as
follows: each mouse received orogastrically 0.5 ml of malate (10% in
0.15 M NaCl) at 10 and 12 a.m. Fecal samples were collected at
2 p.m., and the samples were diluted 1/3 with sterile distilled water. Luciferase activities (Lux) and L. lactis counts were
estimated from these dilutions as previously described (15).
Promoter strength was expressed as the logarithm of the number of
relative light units per 108 CFU.
Different groups of germfree mice inoculated with a single L. lactis strain (gnotoxenic mice) were studied. One day after inoculation, the bacteria were established in the DT, and their populations remained stable (about 108 CFU/g of fecal
sample) for several months. It has been shown previously that this
animal model allows L. lactis to reach a stable population
level in fecal samples (7). However, the metabolic
activities of the bacteria were unknown.
In the present study, luciferase genes were used as biosensors to study
the physiology of L. lactis established in DT. The bacterial
luciferase gene has been shown to be a potential reporter gene in
L. lactis (3, 15). Light emission with intact
cells requires nonaldehyde as the substrate and reduced flavin
mononucleotide (FMN) produced by the bacteria (12). The
availability of reduced FMN depends on the physiological state of the
cells, a condition that restricts the use of luxAB reporter
genes to fully viable cells (8).
We first studied L. lactis JIM5213. In this strain the
lux genes are under control of
PhisD3, a truncated derivative of the histidine
operon promoter which is deregulated in CDM with or without histidine
(Fig. 1A). The amount of Lux activity per L. lactis cell was on the same order of magnitude in
laboratory media and in feces of gnotoxenic mice colonized with
L. lactis (Fig. 1A). This showed that L. lactis
is metabolically active and contains nonlimiting amounts of reduced FMN
when it is established in the DT of gnotoxenic mice.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 1.
Comparison of the expression of the
Phis promoters in culture broth (CDM with and
without histidine) and in gnotoxenic mice colonized with L. lactis. The following two forms of the Phis
promoter were used: PhisD3, which is the
truncated form of Phis (A), and
Phis, which is the wild-type promoter (B). Lux
activities and bacterial counts were determined for each mouse fecal
sample. The vertical bars represent the standard errors of the means.
|
|
The lux construction JIM5206 contains the wild-type
histidine promoter (Phis), which is turned off
and on in CDM with and without histidine, respectively (Fig. 1B). In
gnotoxenic mice, the strength of this promoter was even less than its
strength in CDM with histidine (Fig. 1B). The repression of
Phis was presumably mostly due to the presence
of histidine in fecal samples at a concentration slightly higher than
the concentration in CDM (600 and 360 nmol/g in DT and CDM,
respectively).
In L. lactis JIM5192, lux genes are under the
control of Pald, which is induced in the
presence of the three branched-chain amino acids (isoleucine, leucine,
and valine [ILV]) (Fig. 2A). The Lux
activity in fecal samples was similar to the Lux activity observed in
CDM lacking ILV (Fig. 2B). However, the concentrations of free ILV were
similar in the fecal samples and CDM (400 to 500 nmol/g in DT and CDM,
respectively), suggesting that the absence of the branched-chain amino
acids was not responsible for the low level of promoter expression.
However, Pald has reduced activity under certain
stress conditions. This response is known to be induced by amino acid
starvation and low pH (14). Fusions with other promoters
that reveal specifically different stress responses should be tested to
determine the factor(s) involved in Pald closure
in DT.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 2.
Comparison of the expression of the
Pald promoter in culture broth (CDM with and
without the branched-chain amino acids ILV) (A) and in gnotoxenic mice
colonized by L. lactis (B). The vertical bars represent the
standard errors of the means.
|
|
We tested our ability to stimulate L. lactis in the
DT. To do this, we used JIM5460 containing a fusion with
Pmle, the promoter for malolactic fermentation
genes, which is induced by malate (16). Gnotoxenic mice
harboring JIM5460 received malate orally, and the Lux activity of
L. lactis was measured in fecal samples. The uninduced
Pmle activities were low and similar in fecal
samples and CDM (Fig. 3). A 40-fold
increase was observed after malate was ingested. This increase was
significant, although it was 10-fold lower than the increase observed
in CDM with malate (Fig. 3). Activation was transient, as the Lux
activity reached the uninduced level 1 day after supplementation and
was again inducible another day later (data not shown). It appears that L. lactis is able to adapt its metabolism to this diet
additive. The induction in the DT was not as effective as the induction in the laboratory medium, possibly because the malate given orally may
have been absorbed in the small intestine, leading to reduced malate
availability for L. lactis in the cecum.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 3.
Induction by malate (M) of the expression of the
PmleS promoter in CDM (A) and in gnotoxenic mice
colonized by L. lactis (B). The vertical bars represent the
standard errors of the means.
|
|
To our knowledge, our work considering the total L. lactis
population in the DT is the first work which reports an assessment of
promoter strength in the DT. More information on the metabolic activity
of bacterial cells in the DT could be obtained by using promoters
specific for other pathways and responding to different signals.
Knowledge concerning the expressed genes and metabolic activities of
microorganisms ingested with food is important, as it has been proposed
that some microorganisms are beneficial to human health (4,
10). This new approach for studying bacterial metabolism in vivo
could help determine the role of microorganisms as probiotic organisms.
 |
ACKNOWLEDGMENTS |
We thank G. Miranda for performing the amino acid analysis.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unite
d'Ecologie et de Physiologie Digestive, Unite FBI, Centre de
Recherches de Jouy, INRA, 78352 Jouy-en-Josas Cedex, France. Phone: 01 34 65 24 67. Fax: 01 34 65 24 62. E-mail:
corthier{at}biotec.jouy.inra.fr.
 |
REFERENCES |
| 1.
|
Anagnostopoulos, C., and J. Spizizen.
1961.
Requirements for transformation in Bacillus subtilis.
J. Bacteriol.
81:741-746[Free Full Text].
|
| 2.
|
Ducluzeau, R.,
M. Belier, and P. Raibaud.
1970.
Transit digestif de divers inoculum introduits per os chez les souris axeniques et holoxeniques (conventionnelles): effet antagoniste de la microflore du tractus gastro-intestinal.
Zentbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig.
213:533-548.
|
| 3.
|
Eaton, T. J.,
C. A. Shearman, and M. J. Gasson.
1993.
The use of bacterial luciferase genes as reporter genes in Lactococcus: regulation of the Lactococcus lactis subsp. lactis lactose genes.
J. Gen. Microbiol.
139:1495-1501[Medline].
|
| 4.
|
Elmer, G. W.,
C. M. Surawicz, and L. V. McFarland.
1996.
Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections.
JAMA
275:870-876[Abstract].
|
| 5.
|
Fischetti, V. A.,
D. Medaglini,
M. Oggioni, and G. Pozzi.
1993.
Expression of foreign proteins on gram-positive commensal bacteria for mucosal vaccine delivery.
Curr. Opin. Biotechnol.
4:603-610[Medline].
|
| 6.
|
Godon, J. J.,
K. Jury,
C. A. Shearman, and M. J. Gasson.
1994.
The Lactococcus lactis sex-factor aggregation gene cluA.
Mol. Microbiol.
12:655-663[Medline].
|
| 7.
|
Gruzza, M.,
I. Y. Duval, and R. Ducluzeau.
1992.
Colonization of the digestive tract of germ free mice by genetically engineered strains of Lactococcus lactis: study of recombinant DNA stability.
Microb. Releases
1:165-171[Medline].
|
| 8.
|
Lampinen, J.,
M. Virta, and M. Karp.
1995.
Use of controlled luciferase expression to monitor chemicals affecting protein synthesis.
Appl. Environ. Microbiol.
61:2981-2989[Abstract].
|
| 9.
|
Leenhouts, K.,
J. Kok, and G. Venema.
1991.
Lactococcal plasmid pWVO1 as an integration vector for lactococci.
Appl. Environ. Microbiol.
57:2562-2567[Abstract/Free Full Text].
|
| 10.
|
Marteau, P., and J. C. Rambaud.
1993.
Potential of using lactic acid bacteria for therapy and immunomodulation in man.
FEMS Microbiol. Rev.
12:207-220[Medline].
|
| 11.
|
Medaglini, D.,
G. Pozzi,
T. P. King, and V. A. Fischetti.
1995.
Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization.
Proc. Natl. Acad. Sci. USA
92:6868-6872[Abstract/Free Full Text].
|
| 12.
|
Meighen, E. A.
1991.
Molecular biology of bacterial bioluminescence.
Microbiol. Rev.
55:123-142[Abstract/Free Full Text].
|
| 13.
|
Poolman, B., and W. N. Konings.
1988.
Relation of growth of Streptococcus lactis and Streptococcus cremoris to amino acid transport.
J. Bacteriol.
170:700-707[Abstract/Free Full Text].
|
| 14.
|
Rallu, F.,
A. Gruss, and E. Maguin.
1996.
Lactococcus lactis and stress.
Antonie Leeuwenhoek
70:243-251.
|
| 15.
|
Renault, P.,
G. Corthier,
N. Goupil,
C. Delorme, and S. D. Ehrlich.
1996.
Plasmid vectors for Gram-positive bacteria switching from high to low copy number.
Gene
183:175-182[Medline].
|
| 16.
|
Renault, P.,
C. Gaillardin, and H. Heslot.
1989.
Product of the Lactococcus lactis gene required for malolactic fermentation is homologous to a family of positive regulators.
J. Bacteriol.
171:3108-3114[Abstract/Free Full Text].
|
| 17.
|
Terzaghi, B., and W. E. Sandine.
1975.
Improved medium for lactic streptococci and their bacteriophages.
Appl. Microbiol.
29:807-813.
|
| 18.
|
Wells, J. M.,
K. Robinson,
L. M. Chamberlain,
K. M. Schofield, and R. W. Le Page.
1996.
Lactic acid bacteria as vaccine delivery vehicles.
Antonie Leeuwenhoek
70:317-330.
|
Appl Environ Microbiol, July 1998, p. 2721-2722, Vol. 64, No. 7
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rochat, T., Gratadoux, J.-J., Corthier, G., Coqueran, B., Nader-Macias, M.-E., Gruss, A., Langella, P.
(2005). Lactococcus lactis SpOx Spontaneous Mutants: a Family of Oxidative-Stress-Resistant Dairy Strains. Appl. Environ. Microbiol.
71: 2782-2788
[Abstract]
[Full Text]
-
Oozeer, R., Furet, J. P., Goupil-Feuillerat, N., Anba, J., Mengaud, J., Corthier, G.
(2005). Differential Activities of Four Lactobacillus casei Promoters during Bacterial Transit through the Gastrointestinal Tracts of Human-Microbiota-Associated Mice. Appl. Environ. Microbiol.
71: 1356-1363
[Abstract]
[Full Text]
-
Fernandez, L., Marin, M. L., Langa, S., Martin, R., Reviriego, C., Fernandez, A., Olivares, M., Xaus, J., Rodriguez, J. M.
(2004). A Novel Genetic Label for Detection of Specific Probiotic Lactic Acid Bacteria. Food Science and Technology International
10: 101-108
[Abstract]
-
Bron, P. A., Hoffer, S. M., Van Swam, I. I., De Vos, W. M., Kleerebezem, M.
(2004). Selection and Characterization of Conditionally Active Promoters in Lactobacillus plantarum, Using Alanine Racemase as a Promoter Probe. Appl. Environ. Microbiol.
70: 310-317
[Abstract]
[Full Text]
-
Oozeer, R., Goupil-Feuillerat, N., Alpert, C. A., van de Guchte, M., Anba, J., Mengaud, J., Corthier, G.
(2002). Lactobacillus casei Is Able To Survive and Initiate Protein Synthesis during Its Transit in the Digestive Tract of Human Flora-Associated Mice. Appl. Environ. Microbiol.
68: 3570-3574
[Abstract]
[Full Text]
-
Drouault, S., Juste, C., Marteau, P., Renault, P., Corthier, G.
(2002). Oral Treatment with Lactococcus lactis Expressing Staphylococcus hyicus Lipase Enhances Lipid Digestion in Pigs with Induced Pancreatic Insufficiency. Appl. Environ. Microbiol.
68: 3166-3168
[Abstract]
[Full Text]
-
Drouault, S., Anba, J., Corthier, G.
(2002). Streptococcus thermophilus Is Able To Produce a {beta}-Galactosidase Active during Its Transit in the Digestive Tract of Germ-Free Mice. Appl. Environ. Microbiol.
68: 938-941
[Abstract]
[Full Text]
-
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., Remaut, E.
(2000). Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10. Science
289: 1352-1355
[Abstract]
[Full Text]
-
Geoffroy, M.-C., Guyard, C., Quatannens, B., Pavan, S., Lange, M., Mercenier, A.
(2000). Use of Green Fluorescent Protein To Tag Lactic Acid Bacterium Strains under Development as Live Vaccine Vectors. Appl. Environ. Microbiol.
66: 383-391
[Abstract]
[Full Text]
-
Drouault, S., Corthier, G., Ehrlich, S. D., Renault, P.
(1999). Survival, Physiology, and Lysis of Lactococcus lactis in the Digestive Tract. Appl. Environ. Microbiol.
65: 4881-4886
[Abstract]
[Full Text]